Total Payments
$4,673
2024 Payments
$1,548
Companies
34
Transactions
329
Medicare Patients
3,328
Medicare Billing
$340,183
Payment Breakdown by Category
Food & Beverage$4,673 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,673 | 329 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $691.38 | 54 | $0 (2024) |
| Lilly USA, LLC | $480.00 | 36 | $0 (2024) |
| ABBVIE INC. | $454.14 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $369.30 | 15 | $0 (2024) |
| PFIZER INC. | $221.21 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $219.74 | 21 | $0 (2023) |
| Mylan Specialty L.P. | $200.68 | 13 | $0 (2024) |
| Amgen Inc. | $192.88 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $186.44 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $169.05 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,548 | 91 | Novo Nordisk Inc ($301.81) |
| 2023 | $1,032 | 73 | Novo Nordisk Inc ($200.78) |
| 2022 | $1,161 | 88 | Novo Nordisk Inc ($148.12) |
| 2021 | $858.69 | 71 | AbbVie Inc. ($125.78) |
| 2019 | $24.81 | 2 | Lilly USA, LLC ($12.41) |
| 2018 | $37.83 | 3 | Janssen Pharmaceuticals, Inc ($13.49) |
| 2017 | $10.78 | 1 | Novo Nordisk Inc ($10.78) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Obesity | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Oncology | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.26 | General |
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,046 | 2,019 | $292,814 | $118,392 |
| 2022 | 14 | 836 | 1,897 | $226,258 | $86,921 |
| 2021 | 13 | 792 | 2,032 | $206,818 | $81,229 |
| 2020 | 13 | 654 | 1,320 | $269,709 | $53,641 |
Total Patients
3,328
Total Services
7,268
Medicare Billing
$340,183
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 329 | 605 | $117,370 | $46,996 | 40.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 171 | 171 | $68,058 | $26,885 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 151 | 196 | $25,480 | $10,904 | 42.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 29 | $10,759 | $8,126 | 75.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $18,467 | $7,252 | 39.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 32 | 34 | $16,320 | $7,125 | 43.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 25 | 25 | $9,975 | $3,938 | 39.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $5,346 | $1,702 | 31.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 19 | 19 | $1,805 | $1,440 | 79.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 32 | 33 | $2,640 | $1,338 | 50.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 30 | 31 | $1,333 | $887.53 | 66.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 52 | 73 | $2,595 | $673.47 | 26.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $860.00 | $572.60 | 66.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 19 | 21 | $1,527 | $446.93 | 29.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 51 | 670 | $10,050 | $56.03 | 0.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 22 | $228.36 | $48.40 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 343 | 755 | $146,370 | $57,144 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 146 | 197 | $25,610 | $10,441 | 40.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 52 | 52 | $20,696 | $8,263 | 39.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $5,760 | $2,529 | 43.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $5,947 | $2,242 | 37.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 26 | 26 | $2,470 | $1,827 | 73.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 36 | 36 | $2,880 | $1,483 | 51.5% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 21 | 23 | $1,541 | $764.26 | 49.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 27 | $1,161 | $736.29 | 63.4% |
About Dr. Darin Thomas, MD
Dr. Darin Thomas, MD is a Internal Medicine healthcare provider based in Ferdinand, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508967738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darin Thomas, MD has received a total of $4,673 in payments from pharmaceutical and medical device companies, with $1,548 received in 2024. These payments were reported across 329 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,673).
As a Medicare-enrolled provider, Thomas has provided services to 3,328 Medicare beneficiaries, totaling 7,268 services with total Medicare billing of $340,183. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Ferdinand, IN
- Active Since 09/26/2006
- Last Updated 10/25/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508967738
Products in Payments
- VRAYLAR (Drug) $387.23
- Ozempic (Drug) $259.08
- Rybelsus (Drug) $241.44
- MOUNJARO (Drug) $221.30
- FARXIGA (Drug) $213.10
- JARDIANCE (Drug) $208.96
- TRULICITY (Drug) $187.84
- Kerendia (Drug) $169.05
- GEMTESA (Drug) $156.23
- NURTEC ODT (Drug) $140.29
- XARELTO (Drug) $137.18
- BELSOMRA (Drug) $127.58
- ENTRESTO (Drug) $126.82
- BREZTRI (Drug) $125.12
- Wegovy (Drug) $115.86
- XIFAXAN (Drug) $115.63
- Yupelri (Drug) $115.48
- TRELEGY ELLIPTA (Drug) $115.22
- Otezla (Drug) $94.90
- TRINTELLIX (Drug) $93.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.